Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Acurx Pharmaceuticals, Inc. (ACXP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| Donohue James J. (Director) has filed a Form 4 on Acurx Pharmaceuticals, Inc.|
Txns:
| Granted 10,000 options
@ $2.75, valued at
$27.5k
|
|
| 06/16/2023 |
4
| HARRISON THOMAS L (Director) has filed a Form 4 on Acurx Pharmaceuticals, Inc.|
Txns:
| Granted 10,000 options
@ $2.75, valued at
$27.5k
|
|
| 06/16/2023 |
4
| DEAN JACK H (Director) has filed a Form 4 on Acurx Pharmaceuticals, Inc.|
Txns:
| Granted 10,000 options
@ $2.75, valued at
$27.5k
|
|
| 06/16/2023 |
4
| Sailer Carl (Director) has filed a Form 4 on Acurx Pharmaceuticals, Inc.|
Txns:
| Granted 10,000 options
@ $2.75, valued at
$27.5k
|
|
| 06/16/2023 |
4
| Scodari Joseph C (Director) has filed a Form 4 on Acurx Pharmaceuticals, Inc.|
Txns:
| Granted 10,000 options
@ $2.75, valued at
$27.5k
|
|
| 02/24/2023 |
4
| Shawah Robert G. (CFO) has filed a Form 4 on Acurx Pharmaceuticals, Inc.|
Txns:
| Granted 75,000 options
@ $3.41, valued at
$255.8k
|
|
| 02/24/2023 |
4
| LUCI DAVID P (President and CEO) has filed a Form 4 on Acurx Pharmaceuticals, Inc.|
Txns:
| Granted 130,000 options
@ $3.41, valued at
$443.3k
|
|
| 02/24/2023 |
4
| DELUCCIA ROBERT J (10% Owner) has filed a Form 4 on Acurx Pharmaceuticals, Inc.|
Txns:
| Granted 130,000 options
@ $3.41, valued at
$443.3k
|
|
| 07/29/2022 |
4
| Sailer Carl (Director) has filed a Form 4 on Acurx Pharmaceuticals, Inc.|
Txns:
| Bought 19,737 shares
@ $3.8, valued at
$75k
Bought 19,737 options to buy
@ $3.55, valued at
$70.1k
|
|
| 07/29/2022 |
4
| DELUCCIA ROBERT J (10% Owner) has filed a Form 4 on Acurx Pharmaceuticals, Inc.|
Txns:
| Bought 19,737 shares
@ $3.8, valued at
$75k
Bought 19,737 options to buy
@ $3.55, valued at
$70.1k
|
|
| 07/29/2022 |
4
| LUCI DAVID P (President and CEO) has filed a Form 4 on Acurx Pharmaceuticals, Inc.|
Txns:
| Bought 19,737 shares
@ $3.8, valued at
$75k
Bought 19,737 options to buy
@ $3.55, valued at
$70.1k
|
|
| 11/24/2021 |
4
| Sailer Carl (Director) has filed a Form 4 on Acurx Pharmaceuticals, Inc.|
Txns:
| Bought 5,161 shares
@ $4.84, valued at
$25k
|
|
| 11/22/2021 |
4
| DELUCCIA ROBERT J (10% Owner) has filed a Form 4 on Acurx Pharmaceuticals, Inc.|
Txns:
| Bought 5,034 shares
@ $4.901, valued at
$24.7k
|
|
| 11/22/2021 |
4
| LUCI DAVID P (President and CEO) has filed a Form 4 on Acurx Pharmaceuticals, Inc.|
Txns:
| Bought 5,200 shares
@ $4.8, valued at
$25k
|
|
| 09/10/2021 |
4
| Sailer Carl (Director) has filed a Form 4 on Acurx Pharmaceuticals, Inc.|
Txns:
| Bought 12,500 shares
@ $6, valued at
$75k
|
|
| 07/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2021 |
4
| Sailer Carl (Director) has filed a Form 4 on Acurx Pharmaceuticals, Inc.|
Txns:
| Granted 50,000 options
@ $6.18, valued at
$309k
|
|
| 07/06/2021 |
4
| HARRISON THOMAS L (Director) has filed a Form 4 on Acurx Pharmaceuticals, Inc.|
Txns:
| Granted 50,000 options
@ $6.18, valued at
$309k
|
|
| 07/06/2021 |
4
| Donohue James J. (Director) has filed a Form 4 on Acurx Pharmaceuticals, Inc.|
Txns:
| Granted 50,000 options
@ $6.18, valued at
$309k
|
|
| 07/06/2021 |
4
| DEAN JACK H (Director) has filed a Form 4 on Acurx Pharmaceuticals, Inc.|
Txns:
| Granted 50,000 options
@ $6.18, valued at
$309k
|
|
| 07/06/2021 |
4
| LUCI DAVID P (President and CEO) has filed a Form 4 on Acurx Pharmaceuticals, Inc.|
Txns:
| Granted 350,000 options
@ $6.26, valued at
$2.2M
Granted 500,000 options
@ $6.18, valued at
$3.1M
|
|
| 07/06/2021 |
4
| Shawah Robert G. (CFO) has filed a Form 4 on Acurx Pharmaceuticals, Inc.|
Txns:
| Granted 70,000 options
@ $6.26, valued at
$438.2k
Granted 200,000 options
@ $6.18, valued at
$1.2M
|
|
| 07/06/2021 |
4
| DELUCCIA ROBERT J (10% Owner) has filed a Form 4 on Acurx Pharmaceuticals, Inc.|
Txns:
| Granted 350,000 options
@ $6.26, valued at
$2.2M
Granted 500,000 options
@ $6.18, valued at
$3.1M
|
|
|
|